ELITE HEALTH SYSTEMS (EHSI) Financials

EHSI

FY2025 annual

Revenue $1.0M n/m YoY

Net Income -$7.8M n/m YoY

Free Cash Flow -$2.9M n/m YoY

Operating Cash Flow -$2.9M n/m YoY

Market Cap $23.7M as of Oct 20, 2026

Price / Sales 23.1x on $1.0M revenue, FY2025

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 9.2x on $2.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 19, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EHSI SEC filings page.

ELITE HEALTH SYSTEMS (EHSI) reported $1.0M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EHSI FY2025 2026-10-03

Revenue has returned near FY2021 levels, but the business now consumes cash because operating costs vastly exceed its thin gross profit.

Cash conversion has reversed: revenue was similar in FY2021 and FY2025, yet operating cash flow moved from $174K positive to -$2.9M. Because free cash flow nearly matches operating cash flow, the shortfall reflects day-to-day operations rather than heavy capital spending.

The 2025 revenue base produced only $118K of gross profit, while selling, general and administrative costs reached $4.0M; the resulting cost structure overwhelms gross economics before financing costs are considered.

The balance sheet is currently funded more by new financing than internally generated cash: financing provided $3.7M in FY2025 against operating cash outflow of $2.9M. Current assets exceeded current liabilities by roughly 3.3x, while reported liquidity equaled 15.3 months of the latest annual operating outflow.

Financial Health Signals

Financial health score not available

ELITE HEALTH SYSTEMS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Safe

6.76

ELITE HEALTH SYSTEMS scores 6.76, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $23.7M against total liabilities of $1.4M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/7

ELITE HEALTH SYSTEMS passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing

N/A

ELITE HEALTH SYSTEMS reported a net loss of $7.8M while operations used $2.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.3M

YoYn/m

QoQ-6.3%

ELITE HEALTH SYSTEMS generated $1.3M in revenue in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 6.3%.

Net Income

-$1.5M

YoYn/m

QoQn/m

ELITE HEALTH SYSTEMS reported a net loss of $1.5M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$1.3M

YoY-58.3%

QoQ-50.0%

5Y CAGR-14.3%

10Y CAGR-5.1%

ELITE HEALTH SYSTEMS held $1.3M in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding

29M

YoY+33.2%

QoQ0.0%

5Y CAGR+29.6%

ELITE HEALTH SYSTEMS had 29M shares outstanding in Q2 2026. This represents an increase of 33.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

12.8%

QoQ+4.5pp

ELITE HEALTH SYSTEMS's gross margin was 12.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is up 4.5 percentage points.

Return on Equity

-59.6%

YoY-48.0pp

QoQ-27.8pp

ELITE HEALTH SYSTEMS's quarterly ROE was -59.6% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 48.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 27.8 percentage points.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q2 2026.

EHSI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EHSI quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	N/A	$1.0Mn/m	$0n/m	$0n/m	$0-100.0%	$1.1M-66.6%	$3.2M+3.4%	$3.1M-10.3%	$3.4M+0.3%	$3.4M	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	$906Kn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$118Kn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$4.0M+120.7%	$1.8M+134.4%	$765K-44.8%	$1.4M+30.4%	$1.1M-11.2%	$1.2M-2.7%	$1.2M-4.6%	$1.3M+2.4%	$1.3M-3.7%	$1.3M+6.2%	$1.2M+4.5%	$1.2M+18.6%	$994K-3.9%	$1.0M+9.2%	$947K
Operating Income	N/A	-$3.8Mn/m	-$1.8Mn/m	-$765Kn/m	-$1.4Mn/m	-$88K-105.4%	$1.6M+8.4%	$1.5M+1037.4%	$131K-81.0%	$688K+12.1%	$614K+12.9%	$544K-26.1%	$736Kn/m	-$994K-502.4%	$247K+7.9%	$229K
EBITDA	N/A	-$3.8M	N/A	N/A	N/A	N/A	N/A	$1.5M+33.8%	$1.1M-38.9%	$1.8M+12.5%	$1.6M+9.5%	$1.5M+5.0%	$1.4Mn/m	-$994K-247.7%	$673K-24.4%	$890K
Interest Expense	N/A	N/A	N/A	$2Kn/m	$0-100.0%	$3K-88.0%	$25K-72.5%	$91K-19.5%	$113K-26.1%	$153K-5.0%	$161K-11.0%	$181K-1.6%	$184K+1126.7%	$15K-92.5%	$199K+12.4%	$177K
Income Tax	N/A	$0n/m	-$163Kn/m	$0-100.0%	$39K-90.7%	$420K+30.0%	$323K+3488.9%	$9Kn/m	-$192Kn/m	-$97K-128.4%	$342K+35.7%	$252K+4.1%	$242Kn/m	-$362K-200.0%	$362Kn/m	$0
Net Income	N/A	-$7.8Mn/m	-$2.1Mn/m	-$816Kn/m	-$1.6Mn/m	-$881K-265.3%	$533K+275.4%	$142Kn/m	-$421K-178.3%	$538K+0.4%	$536K+35.4%	$396K-29.4%	$561Kn/m	-$667K-191.5%	$729K+2413.8%	$29K
EPS (Basic)	N/A	-$0.35n/m	-$0.13n/m	-$0.09	-$0.09n/m	-$0.11-257.1%	$0.07+250.0%	$0.02n/m	-$0.05-171.4%	$0.070.0%	$0.07+40.0%	$0.05-28.6%	$0.07n/m	-$0.09-200.0%	$0.09n/m	$0.00
EPS (Diluted)	—	N/A	N/A	-$0.17	-$0.17n/m	-$0.11-257.1%	$0.07+250.0%	$0.02n/m	-$0.05-171.4%	$0.070.0%	$0.07+40.0%	$0.05-28.6%	$0.07n/m	-$0.09-200.0%	$0.09n/m	$0.00
Diluted Shares (Avg)	N/A	N/A	N/A	9M	8M+0.6%	8M0.0%	8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.3Mn/m	$1.4Mn/m	N/A	$0n/m	$0n/m	$0n/m	N/A	$0n/m
Cost of Revenue	$1.1Mn/m	$1.3Mn/m	N/A	N/A	$0	$0	N/A	N/A
Gross Profit	$168Kn/m	$117Kn/m	N/A	N/A	$0	$0	N/A	N/A
SG&A Expenses	$1.7M+284.0%	$1.4M+231.4%	N/A	$1.2M+201.0%	$445K+1.8%	$427K-10.3%	N/A	$387K+156.3%
Operating Income	-$1.5Mn/m	-$1.3Mn/m	N/A	-$1.2Mn/m	-$445Kn/m	-$427Kn/m	N/A	-$387Kn/m
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0n/m
Net Income	-$1.5Mn/m	-$1.3Mn/m	N/A	-$1.2Mn/m	-$441Kn/m	-$424Kn/m	N/A	-$290Kn/m
EPS (Basic)	-$0.05n/m	-$0.05n/m	-$0.26n/m	-$0.05n/m	-$0.02n/m	-$0.02n/m	-$0.05n/m	-$0.02

Not reported in any period shown, so not listed: R&D Expenses, EBITDA, EPS (Diluted), Diluted Shares (Avg).

EHSI Balance Sheet

EHSI quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$6.7M+54.2%	$4.3M+227.1%	$1.3M-24.4%	$1.7M-52.6%	$3.7M-11.6%	$4.2M-16.5%	$5.0M-19.5%	$6.2M-21.6%	$7.9M-4.0%	$8.2M+11.6%	$7.4M-0.9%	$7.5M+48.2%	$5.0M-5.0%	$5.3M+27.1%	$4.2M
Current Assets	$4.5M+5.5%	$4.2M+706.3%	$527K-66.1%	$1.6M-30.7%	$2.2M-25.4%	$3.0M+12.2%	$2.7M-34.0%	$4.1M+10.1%	$3.7M+25.3%	$2.9M+59.3%	$1.8M+21.2%	$1.5M-13.4%	$1.8M-65.1%	$5.0M+271.6%	$1.4M
Cash & Equivalents	$3.8M-6.8%	$4.0M+765.7%	$466K-69.7%	$1.5M-29.4%	$2.2M+7.3%	$2.0M+52.1%	$1.3M-12.1%	$1.5M-43.4%	$2.7M+36.8%	$2.0M+83.7%	$1.1M+1.4%	$1.1M-25.5%	$1.4M-2.5%	$1.4M+74.7%	$830K
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Accounts Receivable	$330Kn/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$346K-2.8%	$356K+11.9%	$318K-58.5%	$767K-13.9%	$891K+42.3%	$626K+126.0%	$277Kn/m	$0-100.0%	$7K-97.8%	$313K
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$984Kn/m	$0	N/A	$0-100.0%	$315Kn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.4M+844.8%	$143K-78.8%	$676K+132.3%	$291K-55.9%	$660K+35.5%	$487K-73.6%	$1.8M-42.3%	$3.2M-28.8%	$4.5M-16.2%	$5.3M+6.4%	$5.0M-8.4%	$5.5M+51.3%	$3.6M+12.5%	$3.2M+14.1%	$2.8M
Current Liabilities	$1.3M+1325.5%	$94K-84.5%	$607K+116.8%	$280K-55.3%	$626K+52.7%	$410K-75.0%	$1.6M-12.9%	$1.9M+16.5%	$1.6M+5.9%	$1.5M+17.3%	$1.3M+21.4%	$1.1M+155.4%	$419K-85.4%	$2.9M+408.5%	$563K
Non-Current Liabilities	$11K-77.6%	$49K-29.0%	$69K+527.3%	$11K-67.6%	$34K-55.8%	$77K-62.6%	$206K-84.3%	$1.3M-54.2%	$2.9M-25.0%	$3.8M+2.6%	$3.7M-15.6%	$4.4M+37.7%	$3.2M+786.5%	$362K-84.0%	$2.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.1M	N/A	$2.9M-23.3%	$3.8M+19.6%	$3.2Mn/m	$0-100.0%	$2.2M
Total Equity	$5.3M+27.2%	$4.2M+547.8%	$645K-47.9%	$1.2M-51.9%	$2.6M-30.1%	$3.7M+16.9%	$3.2M+4.7%	$3.0M-12.3%	$3.4M+18.6%	$2.9M+22.7%	$2.4M+20.2%	$2.0M+40.0%	$1.4M-32.3%	$2.1M+54.4%	$1.3M
Retained Earnings	-$12.2Mn/m	-$4.4Mn/m	-$2.4Mn/m	-$1.7Mn/m	-$373K-173.4%	$508Kn/m	-$25Kn/m	-$167K-165.7%	$254Kn/m	-$284Kn/m	-$820Kn/m	-$1.2Mn/m	-$1.8Mn/m	-$1.1Mn/m	-$1.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$3.9M-1.7%	$5.4M+25.8%	$6.7M+54.2%	$5.3M+39.6%	$4.0M+31.4%	$4.3M+66.1%	$4.3M+227.1%	$3.8M+336.7%
Current Assets	$1.8M-42.2%	$3.3M-12.3%	$4.5M+5.5%	$4.3M+33.9%	$3.2M+41.1%	$3.7M+106.5%	$4.2M+706.3%	$3.2M+451.1%
Cash & Equivalents	$1.3M-58.3%	$2.6M-29.6%	$3.8M-6.8%	$4.0M+25.1%	$3.1M+42.2%	$3.7M+111.2%	$4.0M+765.7%	$3.2M+467.6%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Accounts Receivable	N/A	N/A	$330Kn/m	N/A	N/A	N/A	$0n/m	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$984K	$984K	$984Kn/m	N/A	N/A	N/A	$0	N/A
Total Liabilities	$1.3M+584.3%	$1.4M+1408.8%	$1.4M+844.8%	$291K+103.5%	$197K-80.9%	$91K-96.0%	$143K-78.8%	$143K-29.2%
Current Liabilities	$1.3M+700.6%	$1.4M+2570.6%	$1.3M+1325.5%	$270K+190.3%	$167K-82.9%	$51K-97.7%	$94K-84.5%	$93K-51.3%
Non-Current Liabilities	$11K-63.3%	$11K-72.5%	$11K-77.6%	$21K-58.0%	$30K-48.3%	$40K-38.5%	$49K-29.0%	$50K+354.5%
Total Equity	$2.6M-32.2%	$4.1M-4.0%	$5.3M+27.2%	$5.0M+37.1%	$3.8M+89.3%	$4.2M+1169.7%	$4.2M+547.8%	$3.7M+542.3%
Retained Earnings	-$15.1Mn/m	-$13.5Mn/m	-$12.2Mn/m	-$6.5Mn/m	-$5.3Mn/m	-$4.9Mn/m	-$4.4Mn/m	-$3.4Mn/m

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

EHSI Cash Flow Statement

EHSI quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$4.9M	-$2.9Mn/m	-$1.5Mn/m	-$891Kn/m	-$1.4M-912.1%	$174K-84.4%	$1.1M-27.8%	$1.5M-32.4%	$2.3M-2.6%	$2.3M+26.2%	$1.9M+60.7%	$1.2M+21.8%	$951Kn/m	-$980K-213.8%	$861K+32.9%	$648K
Depreciation & Amortization	N/A	$6K	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$983K-13.4%	$1.1M+12.8%	$1.0M+7.6%	$935K+39.1%	$672Kn/m	$0-100.0%	$426K-35.6%	$661K
Stock-Based Compensation	N/A	$569Kn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2K
Capital Expenditures	N/A	$7Kn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$341K-77.9%	$1.5Mn/m	$0	N/A	N/A
Free Cash Flow	N/A	-$2.9Mn/m	-$1.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.9M+127.8%	$817Kn/m	-$590Kn/m	-$980K	N/A	N/A
Investing Cash Flow	-$308K	-$1.1M-504.6%	$263Kn/m	-$180K-123.3%	$772K+1125.4%	$63K-86.8%	$479Kn/m	-$334Kn/m	-$2.4Mn/m	-$595K-1903.0%	$33K	N/A	N/A	$3.2M+1592.1%	$190K+146.8%	$77K
Financing Cash Flow	$3.4M	$3.7M-22.7%	$4.8Mn/m	$0n/m	$0n/m	-$89Kn/m	-$901Kn/m	-$1.4Mn/m	-$1.1Mn/m	-$1.0Mn/m	-$1.0M	N/A	N/A	-$2.3Mn/m	-$431Kn/m	-$715K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$1.4Mn/m	-$1.3Mn/m	-$1.5Mn/m	-$817Kn/m	-$334Kn/m	-$297Kn/m	-$527Kn/m	-$72K-140.7%
Stock-Based Compensation	$41Kn/m	$41Kn/m	N/A	N/A	$0	$0	N/A	N/A
Investing Cash Flow	$0n/m	$0n/m	-$83K-131.6%	-$225Kn/m	-$241Kn/m	-$515Kn/m	$263Kn/m	$0n/m
Financing Cash Flow	$53Kn/m	$100K-78.9%	$1.4M+21.2%	$1.9M+80.1%	$0-100.0%	$474K-72.8%	$1.1Mn/m	$1.1Mn/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

EHSI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EHSI quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	11.5%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-374.9%	N/A	N/A	N/A	-8.3%-59.2pp	50.9%+2.4pp	48.5%+44.7pp	3.8%-16.3pp	20.2%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-762.1%	N/A	N/A	N/A	-83.0%-99.8pp	16.8%+12.2pp	4.6%+16.9pp	-12.3%-28.1pp	15.8%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-146.9%-97.7pp	-49.2%+77.3pp	-126.5%+0.4pp	-126.9%-92.7pp	-34.2%-48.7pp	14.5%+10.0pp	4.5%+18.5pp	-14.0%-29.7pp	15.7%-2.8pp	18.5%+1.7pp	16.8%-11.8pp	28.6%+76.2pp	-47.6%-82.9pp	35.3%+33.1pp	2.2%
Return on Assets	-117.1%-69.5pp	-47.6%+14.2pp	-61.8%+28.2pp	-90.0%-66.1pp	-23.9%-36.7pp	12.8%+9.9pp	2.8%+9.6pp	-6.8%-13.6pp	6.8%+0.3pp	6.5%+1.1pp	5.4%-2.2pp	7.5%+20.8pp	-13.3%-27.0pp	13.8%+13.1pp	0.7%
Current Ratio	3.35-41.9x	45.20+44.3x	0.87-4.7x	5.55+2.0x	3.58-3.8x	7.33+5.7x	1.64-0.5x	2.16-0.1x	2.28+0.4x	1.93+0.5x	1.420.0x	1.43-2.8x	4.20+2.4x	1.76-0.6x	2.41
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	1.19	N/A	1.25-0.7x	1.96-0.3x	2.29+2.3x	0.00-1.6x	1.62
Liabilities-to-Equity	0.25+0.2x	0.03-1.0x	1.05+0.8x	0.230.0x	0.26+0.1x	0.13-0.5x	0.58-0.5x	1.06-0.2x	1.31-0.5x	1.85-0.3x	2.13-0.7x	2.80+0.2x	2.59+1.0x	1.56-0.6x	2.11
Asset Turnover	0.15+0.2x	0.000.0x	0.000.0x	0.00-0.3x	0.29-0.5x	0.76+0.1x	0.61+0.1x	0.55+0.1x	0.43	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	-287.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	12.8%	8.4%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-117.6%	-92.8%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-117.0%	-92.6%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-59.6%-48.0pp	-31.9%-21.8pp	N/A	-23.1%-15.2pp	-11.7%+9.9pp	-10.0%+83.7pp	N/A	-7.9%+14.4pp
Return on Assets	-39.1%-28.0pp	-23.8%-14.0pp	N/A	-21.9%-14.2pp	-11.1%+3.2pp	-9.8%+2.2pp	N/A	-7.6%+7.0pp
Current Ratio	1.37-17.6x	2.40-70.7x	3.35-41.9x	15.83-18.5x	18.93+16.6x	73.14+72.3x	45.20+44.3x	34.31+31.3x
Liabilities-to-Equity	0.52+0.5x	0.34+0.3x	0.25+0.2x	0.060.0x	0.05-0.5x	0.02-6.8x	0.03-1.0x	0.04-0.3x
Asset Turnover	0.33+0.3x	0.26+0.3x	N/A	0.000.0x	0.000.0x	0.000.0x	N/A	0.000.0x

Not reported in any period shown, so not listed: Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Where ELITE HEALTH SYSTEMS Ranks

Frequently Asked Questions

What is ELITE HEALTH SYSTEMS's annual revenue?

ELITE HEALTH SYSTEMS (EHSI) reported $1.0M in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is ELITE HEALTH SYSTEMS profitable?

No, ELITE HEALTH SYSTEMS (EHSI) reported a net loss of $7.8M in fiscal year 2025.

What is ELITE HEALTH SYSTEMS's EBITDA?

ELITE HEALTH SYSTEMS (EHSI) had EBITDA of -$3.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is ELITE HEALTH SYSTEMS's gross margin?

ELITE HEALTH SYSTEMS (EHSI) had a gross margin of 11.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is ELITE HEALTH SYSTEMS's return on equity (ROE)?

ELITE HEALTH SYSTEMS (EHSI) has a return on equity of -146.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ELITE HEALTH SYSTEMS's free cash flow?

ELITE HEALTH SYSTEMS (EHSI) recorded an outflow of $2.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is ELITE HEALTH SYSTEMS's operating cash flow?

ELITE HEALTH SYSTEMS (EHSI) recorded an outflow of $2.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are ELITE HEALTH SYSTEMS's total assets?

ELITE HEALTH SYSTEMS (EHSI) had $6.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are ELITE HEALTH SYSTEMS's capital expenditures?

ELITE HEALTH SYSTEMS (EHSI) invested $7K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does ELITE HEALTH SYSTEMS have outstanding?

ELITE HEALTH SYSTEMS (EHSI) had 29M shares outstanding as of fiscal year 2025.

What is ELITE HEALTH SYSTEMS's current ratio?

ELITE HEALTH SYSTEMS (EHSI) had a current ratio of 3.35 as of fiscal year 2025, which is generally considered healthy.

What is ELITE HEALTH SYSTEMS's liabilities-to-equity ratio?

ELITE HEALTH SYSTEMS (EHSI) had a liabilities-to-equity ratio of 0.25 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

What is ELITE HEALTH SYSTEMS's return on assets (ROA)?

ELITE HEALTH SYSTEMS (EHSI) had a return on assets of -117.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ELITE HEALTH SYSTEMS's P/E ratio?

ELITE HEALTH SYSTEMS (EHSI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $23.7M as of Oct 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is ELITE HEALTH SYSTEMS's price-to-sales ratio?

ELITE HEALTH SYSTEMS (EHSI) trades at 23.1x sales, its market capitalization divided by $1.0M revenue, FY2025. The market capitalization is $23.7M as of Oct 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does ELITE HEALTH SYSTEMS's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, ELITE HEALTH SYSTEMS (EHSI) held $3.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.9M over that year. Dividing the one by the other, the reported balance equals about 15 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is ELITE HEALTH SYSTEMS's Altman Z-Score?

ELITE HEALTH SYSTEMS (EHSI) has an Altman Z-Score of 6.76, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is ELITE HEALTH SYSTEMS's Piotroski F-Score?

ELITE HEALTH SYSTEMS (EHSI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ELITE HEALTH SYSTEMS's earnings high quality?

ELITE HEALTH SYSTEMS (EHSI) reported a net loss of $7.8M while operations used $2.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.